Last reviewed · How we verify
Newton Laboratories, Inc. — Portfolio Competitive Intelligence Brief
1 marketed
0 filed
0 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| Allergies | CAPSICUM | marketed | Standardized Insect Venom Allergenic Extract [EPC] | Immunology |
Therapeutic area mix
- Immunology · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Assiut University · 1 shared drug class
- Barbara Ann Karmanos Cancer Institute · 1 shared drug class
- Center for Human Reproduction · 1 shared drug class
- Guna spa · 1 shared drug class
- Suez Canal University · 1 shared drug class
- Value Outcomes Ltd. · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Newton Laboratories, Inc.:
- Newton Laboratories, Inc. pipeline updates — RSS
- Newton Laboratories, Inc. pipeline updates — Atom
- Newton Laboratories, Inc. pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Newton Laboratories, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/newton-laboratories-inc. Accessed 2026-05-16.